Cargando…
GPR110 promotes progression and metastasis of triple-negative breast cancer
Breast cancer is the most common type of cancer in women, and approximately 70% of all breast cancer patients use endocrine therapy, such as estrogen receptor modulators and aromatase inhibitors. In particular, triple-negative breast cancer (TNBC) remains a major threat due to the lack of targeted t...
Autores principales: | Nam, Hye-Jung, Kim, Yeon-Ju, Kang, Jae-Hyeok, Lee, Su-Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132940/ https://www.ncbi.nlm.nih.gov/pubmed/35614051 http://dx.doi.org/10.1038/s41420-022-01053-x |
Ejemplares similares
-
Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022) -
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
por: Andradas, Clara, et al.
Publicado: (2016) -
The role of GPR110 in lung cancer progression
por: Ma, Benting, et al.
Publicado: (2020) -
GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma
por: Ahn, Hye-Mi, et al.
Publicado: (2021) -
Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo
por: Jeon, Hyein, et al.
Publicado: (2016)